By Brian Yermal Jr. Top Stories The Environmental Protection Agency has delayed the release of a study that shows the possible cancer risks from formaldehyde, according to internal communications, which comes after recent complaints that the agency and the White House considered blocking the release of a study on water contamination by chemicals used in […]
By Brian Yermal Jr. Top Stories The House passed “right-to-try” legislation in a 250-169 vote on Tuesday that would allow patients who suffer from life-threatening illnesses and have exhausted all available treatment options to obtain experimental medications not approved by the Food and Drug Administration. President Donald Trump is expected to sign the Senate-passed bill, […]
By Brian Yermal Jr. Top Stories The number of people with health insurance stayed about the same last year, according to the Centers for Disease Control and Prevention, despite the Trump administration’s efforts to weaken the Affordable Care Act by pulling enrollment advertisements, distributing social media videos critical of the ACA and declaring the law […]
By Brian Yermal Jr. Top Stories The Justice Department reversed a Drug Enforcement Administration order against Louisiana drug wholesaler Morris & Dickson Co. that stopped its opioid sales over allegations that the company failed to report unusually large orders for the drugs by pharmacies. Five days after the DEA’s order in early May, U.S. District […]
By Jon Reid Week in Review Trump administration President Donald Trump delivered a speech outlining a plan to address high drug prices. Trump stopped short of embracing his campaign pledge to allow Medicare to negotiate lower prices with drug manufacturers, instead focusing on proposals aimed at expanding generic competition and targeting pharmacy benefit managers, among other policy […]
By Jon Reid Top Stories President Donald Trump, in his speech on his plan to curb high prescription drug costs, will not call for one of his most popular campaign promises: allowing Medicare to negotiate lower prices with manufacturers, senior administration officials said. As a presidential candidate, Trump broke with most of his party in […]
By Jon Reid Top Stories In a speech scheduled for Friday, President Donald Trump is expected to lay out a plan for lowering drug costs in the United States that focuses on forcing higher pharmaceutical prices in foreign countries whose governments make drugs more affordable. Trump is also expected to target pharmacy benefit managers, which have […]
By Jon Reid Top Stories Lawmakers on both sides of the aisle raised concerns about White House’s request for Congress to rescind about $7 billion in funding authorized for the popular Children’s Health Insurance Program that has not been spent. The proposed cuts, which Trump administration officials said are not expected to impact the program’s […]
By Jon Reid Morning Consult has published the latest edition of its monthly Trump Tracker, showing the president’s approval state by state, month over month. See it here. Top Stories Dublin-based Shire PLC agreed to be acquired by Japan’s Takeda Pharmaceutical Co. in a deal valued at $62 billion. The agreement, which caps Takeda’s monthlong […]
Information never stops. We help you start your day by making sense of it all. Over 150,000 government and industry executives rely on Morning Consult to stay informed. Our original reporting and morning email briefings make it possible for you to know everything you need to know, every day, at the intersection of Wall Street and business strategy, policy and politics.
